India To Start Clinical Trials Of U.S Based 2nd Gen Vaccines
As per reports, India has planned to start clinical trials of the US- based Akston Biosciences' second generation COVID-19 vaccine. Reportedly, the vaccine can be produced at a much lower cost, that requires no refrigeration and has a shelf life of six months. Moreover, samples of the vaccine has been sent to a government laboratory to check for safety prior to starting clinical trials in India, as per reports .
Tags: covid 19, Covid Vaccine, India, Clinical Trials, Aston biosciences
Courtesy: News 18
Bharat Biotech To Start Phase 2/3 Trials Of Covaxin On Children Aged 2-18
Indigenous vaccine maker Bharat Biotech will soon begin the phase 2/3 clinical trials of its COVID-19 vaccine 'Covaxin' on children aged between 2-18. The request for clinical trials was approved by the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation on May 11. The approval has been granted keeping in view the reports, which have indicated that the third wave is likely to be harsh on children.
Tags: Bharat biotech, Covaxin, Covid-19, Clinical Trials
Courtesy: Times Now News